Home › Entities › clinical_trial › Safety and Immunogenicity Study of Inactivated Vaccine for Prophylaxis of SARS CoV-2 Infection (COVID-19)

Safety and Immunogenicity Study of Inactivated Vaccine for Prophylaxis of SARS CoV-2 Infection (COVID-19)

clinical trial
MedicalStudy clinical_trial Q92274099
Press Enter · cited answer in seconds

Safety and Immunogenicity Study of Inactivated Vaccine for Prophylaxis of SARS CoV-2 Infection (COVID-19)

Summary

Safety and Immunogenicity Study of Inactivated Vaccine for Prophylaxis of SARS CoV-2 Infection (COVID-19) is a clinical trial[1].

Key Facts

  • Safety and Immunogenicity Study of Inactivated Vaccine for Prophylaxis of SARS CoV-2 Infection (COVID-19) is in the country of People's Republic of China[2].
  • Safety and Immunogenicity Study of Inactivated Vaccine for Prophylaxis of SARS CoV-2 Infection (COVID-19)'s instance of is recorded as clinical trial[3].
  • Safety and Immunogenicity Study of Inactivated Vaccine for Prophylaxis of SARS CoV-2 Infection (COVID-19)'s start time is recorded as +2020-04-16T00:00:00Z[4].
  • Safety and Immunogenicity Study of Inactivated Vaccine for Prophylaxis of SARS CoV-2 Infection (COVID-19)'s end time is recorded as +2020-08-13T00:00:00Z[5].
  • Safety and Immunogenicity Study of Inactivated Vaccine for Prophylaxis of SARS CoV-2 Infection (COVID-19)'s main subject is recorded as CoronaVac[6].
  • Safety and Immunogenicity Study of Inactivated Vaccine for Prophylaxis of SARS CoV-2 Infection (COVID-19)'s number of participants is recorded as {'unit': '1', 'amount': '+744'}[7].
  • Safety and Immunogenicity Study of Inactivated Vaccine for Prophylaxis of SARS CoV-2 Infection (COVID-19)'s title is recorded as A Randomized, Double-Blinded, Placebo-Controlled, Phase Ⅰ/Ⅱ Clinical Trial, to Evaluate the Safety and Immunogenicity of the SARS-CoV-2 Inactivated Vaccine in Healthy Adults Aged 18~59 Years[8].
  • Safety and Immunogenicity Study of Inactivated Vaccine for Prophylaxis of SARS CoV-2 Infection (COVID-19)'s minimum age is recorded as {'unit': 'http://www.wikidata.org/entity/Q577', 'amount': '+18'}[9].
  • Safety and Immunogenicity Study of Inactivated Vaccine for Prophylaxis of SARS CoV-2 Infection (COVID-19)'s ClinicalTrials.gov ID is recorded as NCT04352608[10].
  • Safety and Immunogenicity Study of Inactivated Vaccine for Prophylaxis of SARS CoV-2 Infection (COVID-19)'s maximum age is recorded as {'unit': 'http://www.wikidata.org/entity/Q577', 'amount': '+59'}[11].
  • Safety and Immunogenicity Study of Inactivated Vaccine for Prophylaxis of SARS CoV-2 Infection (COVID-19)'s research intervention is recorded as CoronaVac[12].
  • Safety and Immunogenicity Study of Inactivated Vaccine for Prophylaxis of SARS CoV-2 Infection (COVID-19)'s clinical trial phase is recorded as phase I clinical trial[13].
  • Safety and Immunogenicity Study of Inactivated Vaccine for Prophylaxis of SARS CoV-2 Infection (COVID-19)'s clinical trial phase is recorded as phase II clinical trial[14].
  • Safety and Immunogenicity Study of Inactivated Vaccine for Prophylaxis of SARS CoV-2 Infection (COVID-19)'s research subject recruitment status is recorded as recruiting[15].
  • Safety and Immunogenicity Study of Inactivated Vaccine for Prophylaxis of SARS CoV-2 Infection (COVID-19)'s study type is recorded as interventional study[16].

References

Programmatic citations — every numbered marker resolves to a verifiable graph row below.

Direct Wikidata claims

  1. [2] ↑ . wikidata.org.
  2. [3] ↑ . wikidata.org.
  3. [4] ↑ . wikidata.org.
  4. [5] ↑ . wikidata.org.
  5. [6] ↑ . covid-19tracker.milkeninstitute.org. Retrieved . covid-19tracker.milkeninstitute.org. Provenance: wikidata.org.
  6. [7] ↑ . wikidata.org.
  7. [8] ↑ . wikidata.org.
  8. [9] ↑ . wikidata.org.
  9. [10] ↑ . wikidata.org.
  10. [11] ↑ . wikidata.org.
  11. [12] ↑ . covid-19tracker.milkeninstitute.org. Retrieved . covid-19tracker.milkeninstitute.org. Provenance: wikidata.org.
  12. [13] ↑ . wikidata.org.
  13. [14] ↑ . wikidata.org.
  14. [15] ↑ . wikidata.org.
  15. [16] ↑ . wikidata.org.

Class ancestry

  1. [1] ↑ . Wikidata. wikidata.org.

📑 Cite this page

Use these citations when quoting this entity in research, articles, AI prompts, or wherever provenance matters. We aggregate Wikidata + Wikipedia + authoritative open-data sources; the stitched, scored, cross-referenced view is what 4ort.xyz contributes.

APA 4ort.xyz Knowledge Graph. (2026). Safety and Immunogenicity Study of Inactivated Vaccine for Prophylaxis of SARS CoV-2 Infection (COVID-19). Retrieved May 3, 2026, from https://4ort.xyz/entity/safety-and-immunogenicity-study-of-inactivated-vaccine-for-prophylaxis-of-sars-cov-2-infection-covid-19-
MLA “Safety and Immunogenicity Study of Inactivated Vaccine for Prophylaxis of SARS CoV-2 Infection (COVID-19).” 4ort.xyz Knowledge Graph, 4ort.xyz, 3 May. 2026, https://4ort.xyz/entity/safety-and-immunogenicity-study-of-inactivated-vaccine-for-prophylaxis-of-sars-cov-2-infection-covid-19-.
BibTeX @misc{4ortxyz_safety-and-immunogenicity-study-of-inactivated-vaccine-for-prophylaxis-of-sars-cov-2-infection-covid-19-_2026, author = {{4ort.xyz Knowledge Graph}}, title = {{Safety and Immunogenicity Study of Inactivated Vaccine for Prophylaxis of SARS CoV-2 Infection (COVID-19)}}, year = {2026}, url = {https://4ort.xyz/entity/safety-and-immunogenicity-study-of-inactivated-vaccine-for-prophylaxis-of-sars-cov-2-infection-covid-19-}, note = {Accessed: 2026-05-03}}
LLM prompt According to 4ort.xyz Knowledge Graph (aggregator of Wikidata, Wikipedia, and authoritative open-data sources): Safety and Immunogenicity Study of Inactivated Vaccine for Prophylaxis of SARS CoV-2 Infection (COVID-19) — https://4ort.xyz/entity/safety-and-immunogenicity-study-of-inactivated-vaccine-for-prophylaxis-of-sars-cov-2-infection-covid-19- (retrieved 2026-05-03)

Canonical URL: https://4ort.xyz/entity/safety-and-immunogenicity-study-of-inactivated-vaccine-for-prophylaxis-of-sars-cov-2-infection-covid-19- · Last refreshed: